Skip to main content
BioGaia logo

BioGaia — Investor Relations & Filings

Ticker · BIOG ISIN · SE0017769995 LEI · 549300UBUJOY2L7TT361 ST Manufacturing
Filings indexed 610 across all filing types
Latest filing 2024-10-17 Earnings Release
Country SE Sweden
Listing ST BIOG

About BioGaia

https://www.biogaia.com/

BioGaia is a healthcare and biotechnology company that is a world leader in probiotics. A pioneer in microbiome research for over 30 years, the company develops, markets, and sells a range of clinically proven probiotic products. Its portfolio is centered on its patented probiotic strain, Lactobacillus reuteri. These products, typically offered as food supplements, are designed to support the health and well-being of consumers at all stages of life.

Recent filings

Filing Released Lang Actions
BioGaias preliminära resultat för tredje kvartalet nådde inte marknadens förväntningar
Earnings Release Classification · 100% confidence The document is a press release dated October 17, 2024, providing preliminary financial results for the third quarter (Q3) of 2024. It details key figures like preliminary sales (304 MSEK) and operating income (41 MSEK), and mentions a non-cash impairment charge. Crucially, it states: "BioGaia publicerar delårsrapporten för tredje kvartalet tisdagen den 22 oktober 2024 kl. 08:00 CEST, följt av en audiocast kl. 09:30 CEST." This indicates the document is an announcement *about* the upcoming release of the full quarterly report, not the comprehensive report itself. Since it contains preliminary financial highlights for a period shorter than a year, it aligns best with an Earnings Release (ER). Although it announces a future report, the primary content is the preliminary earnings figures, making ER more specific than RPA or RNS. The document is short and acts as a pre-announcement of results. Q3 2024
2024-10-17 Swedish
Förändrat antal aktier och röster i BioGaia AB (publ)
Share Issue/Capital Change Classification · 100% confidence The document is a press release from BioGaia announcing a change in the total number of shares and votes due to the exercise of warrants from an incentive program. This falls under the category of capital changes and share issuance announcements, which is specifically defined as 'Share Issue/Capital Change' (SHA).
2024-09-30 Swedish
Change in the number of shares and votes in BioGaia AB (publ)
Share Issue/Capital Change Classification · 100% confidence The document explicitly states a change in the number of shares and votes due to the exercise of warrants under an incentive program. This constitutes a change in the company's capital structure and share count, which falls under the category of Share Issue/Capital Change.
2024-09-30 English
Förändrat antal aktier och röster i BioGaia AB (publ)
Report Publication Announcement Classification · 99% confidence The provided document text is extremely short (503 characters) and contains only contact information, social media links, and a subscription prompt. It does not contain any financial results, regulatory headers (like 10-K or IR), or specific details about a meeting or transaction. This structure strongly suggests it is a boilerplate footer or a very brief announcement wrapper, rather than a substantive report. Given the brevity and lack of specific content, it is most appropriately classified as a general Regulatory Filing (RNS) or potentially a placeholder, but RNS serves as the best general regulatory fallback for non-specific announcements.
2024-08-30 Swedish
Change in the number of shares and votes in BioGaia AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly details a 'Change in the number of shares and votes in BioGaia AB (publ)' due to the exercise of warrants, resulting in an increase in Class B shares and total votes. It provides the new total number of shares and votes as of a specific date (August 30, 2024). This content directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA), which covers new share issues and capital structure changes. It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a transaction in own shares (POS) as it describes the result of an incentive program exercise, leading to an increase in outstanding shares.
2024-08-30 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding ('Holder: EQT Fund Management S.à r.l.') involving a 'Sell' transaction dated 27/08/2024, resulting in a new holding percentage of 3.70281%. This structure, focusing on the notification of changes in significant share ownership levels and the resulting distribution of holdings, directly matches the definition of a Major Shareholding Notification. The corresponding code is MRQ.
2024-08-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.